Minimal Residual Disease Detection by Heteroduplex PCR in Canine B-Cell Lymphoma Treated with L-CHOP Protocol
World Small Animal Veterinary Association World Congress Proceedings, 2015
S. Sirivisoot1; K. Sajjaviriyakul2; P. Teewasutrakul2; S. Techangamsuwan3; A. Rungsipipat3
1PhD Candidate, Veterinary Pathobiology Program, Department of Veterinary Pathology, Chulalongkorn University, Bangkok, Thailand; 2Oncology Clinic Small Animal Teaching Hospital, Chulalongkorn University, Bangkok, Thailand; 3Companion Animal Cancer Research Unit, Department of Veterinary Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand

Introduction

Canine lymphoma is frequently found and has malignancy behavior. Both B and T neoplastic lineages are expanded and developed to lymphoma. Even this transformed malignancy is good response to multidrug chemotherapy, particularly CHOP or L-CHOP protocol; the recurrence remains occurred.

Objectives

To determine the minimal residual disease (MRD) in dogs before and after treatment with L-CHOP and evaluate the response.

Methods

Four dogs were diagnosed as multicentric B-cell lymphoma by cytology, histopathology and immunophenotyping employing with Pax5 and CD3 antibodies. Then, they were treated with modified L-CHOP protocol (L-asparaginase, vincristine, cyclophosphamide, doxorubicin and prednisolone). Whole blood was collected and evaluated for MRD by heteroduplex PCR detecting antigen receptor rearrangement (PARR) at week 0, 4 and 8, respectively.

Results

Histological assessment based on updated Kiel's classification showed that all four lymphomas were derived from B lymphocytes (Pax5+/CD3-). Three cases were high grade B-cell lymphoma; immunoblastic (n = 2), centroblastic polymorphic type (n = 1), while another was prolymphocytic, low grade B-cell lymphoma. Minimal residual disease of high grade B-cell lymphomas were absent in week 4 and 8 after treatments while that of low grade B-cell lymphoma remained presented. However, T-cell receptor γ genes were detected in week 8 from centroblastic polymorphic high grade B-cell lymphoma, observed a relapsing disease in week 10.

Conclusions

High grade B-cell lymphoma is sensitive to anti-cancer drugs than low grade B-cell lymphoma. Besides, two different clones of lymphoproliferative malignancies could develop in the dog. Thus, heteroduplex PARR could be used to monitor MRD in canine lymphoma and follow up for the recurrence.

  

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

S. Sirivisoot
Veterinary Pathobiology Program
Department of Veterinary Pathology
Chulalongkorn University
Bangkok, Thailand


MAIN : Oncology : Minimal Residual Disease Detection by Heteroduplex PCR
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27